Viby J, Denmark

Anne Staudt Kvistgaard

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Anne Staudt Kvistgaard

Introduction

Anne Staudt Kvistgaard is a notable inventor based in Viby J, Denmark. She has made significant contributions to the field of immunology through her innovative research and inventions. With a total of three patents to her name, Kvistgaard is recognized for her work in enhancing immune responsiveness.

Latest Patents

One of her latest patents focuses on mammalian milk osteopontin for enhancing immune responsiveness. This invention provides mammalian milk osteopontin and/or an active truncation or active peptide thereof to improve immune responsiveness to infectious diseases in mammals, including humans. The invention also enhances the efficacy of vaccinations for both prophylactic and therapeutic treatments of infectious diseases. Furthermore, it includes a vaccine system that combines a vaccine with mammalian milk osteopontin for oral administration, along with methods to enhance immune resistance through this combination.

Career Highlights

Anne Staudt Kvistgaard is currently associated with Arla Foods Amba, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of immune responses and the potential applications of mammalian milk components in medical treatments.

Collaborations

Some of her notable coworkers include Peter Langborg Wejse and Sharon Donovan, who contribute to her research endeavors and collaborative projects.

Conclusion

Anne Staudt Kvistgaard's innovative work in the field of immunology, particularly her patents related to mammalian milk osteopontin, showcases her commitment to enhancing health outcomes through scientific advancements. Her contributions are paving the way for new therapeutic approaches in the treatment of infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…